Expansion of Medicare Coverage for Eversense E3 Continuous Glucose Monitoring System
On February 12, 2024, Ascensia Diabetes Care and Senseonics made an exciting announcement regarding the Eversense E3 Continuous Glucose Monitoring...
Tonix Pharmaceuticals Receives FDA Clearance for Phase 2 OASIS Trial of TNX102 SL for Acute Stress Disorders
On February 12, 2024, Tonix Pharmaceuticals received clearance from the FDA for its Investigational New Drug (IND) application regarding the...
Calidi Biotherapeutics Unveils Revolutionary Systemic Enveloped Oncolytic Virotherapy Platform
On February 12, 2024, Calidi Biotherapeutics will unveil groundbreaking details about its revolutionary systemic enveloped oncolytic virotherapy platform, a promising...
Immunovant Reports Impressive Quarterly Performance and Strong Financial Position
On February 12, 2024, Immunovant (NASDAQ: IMVT) unveiled its impressive quarterly performance, surpassing market expectations with a loss per share...
Loop Capital Analyst Downgrades Big Lots to Sell Rating with Revised Price Target
On February 12, 2024, Loop Capital analyst Anthony Chukumba made a significant move by downgrading Big Lots (NYSE: BIG) from...
Precision Biosciences Announces Groundbreaking Partnership with TG Therapeutics for Development of Azercel in Autoimmune Diseases and NonCancer Indications
On February 12, 2024, Precision Biosciences announced a groundbreaking partnership with TG Therapeutics. This collaboration involves an exclusive license for...
Digital World Acquisition Corp Finalizes Retention Bonus Agreement with TMTG to Retain Key Personnel
As of February 12, 2024, Digital World Acquisition Corp (DWAC) has finalized a retention bonus agreement with TMTG, ensuring the...
EscharEx Outperforms SANTYL in Treating Chronic Venous Leg Ulcers
MediWound has recently released the findings of a comprehensive analysis comparing the effectiveness of EscharEx and Collagenase SANTYL Ointment in...
Bristol Myers Squibb and RayzeBio Move Closer to Merger Completion
On February 12, 2024, Bristol Myers Squibb and RayzeBio announced a significant development in their merger agreement. The waiting period...
Analyst Upgrades Willis Towers Watson Rating and Raises Price Target Signaling Positive Outlook
On February 12, 2024, an intriguing development took place in the financial realm as Citigroup analyst Michael Ward made a...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
